Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

125 works

Work: Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins

  1. Cancer Stem Cell Metabolism

    Fidelia B. Alvina, Arvin M. Gouw, Anne Le

    Article20213 citations
    ABI

  2. Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy

    X. Xia, Zongxin Yang, Qisi Lu +6

    Review article20242 citations
    ABI

  3. Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors

    Parnaz Merikhian, Behrad Darvishi, Neda Jalili +10

    Article20212 citations
    ABI

  4. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance

    Taniya Saha, Kiven Erique Lukong

    Review article20222 citations
    ABI

  5. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy

    Asha Borah, Sreejith Raveendran, Ankit Rochani +2

    Review article20152 citations
    ABI

  6. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

    Erik Ames, Robert J. Canter, Steven K. Grossenbacher +11

    Article20152 citations
    ABI

  7. Cancer stem cells

    Zuoren Yu, Timothy G. Pestell, Michael P. Lisanti +1

    Review article20122 citations
    ABI

  8. Overcoming Antigen Escape with CAR T-cell Therapy

    Hollie J. Jackson, Renier J. Brentjens

    Other20152 citations
    ABI

  9. Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model

    Juan Fu, Yuhong Shang, Qian Zhang +5

    Article20202 citations
    ABI

  10. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors

    Koichi Hirabayashi, Hongwei Du, Yang Xu +8

    Article20212 citations
    ABI

  11. Circulating tumor cells in neuroblastoma: Current status and future perspectives

    Ran Yang, Shan Zheng, Rui Dong

    Review article20222 citations
    ABI

  12. Co-opting signalling molecules enables logic-gated control of CAR T cells

    Aidan M. Tousley, Maria Caterina Rotiroti, Louai Labanieh +15

    Article20232 citations
    ABI

  13. Affinity fine-tuning anti-CAIX CAR-T cells mitigate on-target off-tumor side effects

    Yufei Wang, Alicia Buck, Brandon Piel +26

    Article20242 citations
    ABI

  14. Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma

    James J. Wu, Armin Ghobadi, Richard T. Maziarz +6

    Article20242 citations
    ABI

  15. Enhancing CAR T‐cell therapy manufacturing efficiency through semi‐automated bioprocessing

    J. H. Isaacson, Prajakta Bhanap, Nicholas H. Putnam +7

    Article20252 citations
    ABI

  16. Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives

    Sarkar Sardar Azeez, Raya Kh. Yashooa, Shukur Wasman Smail +4

    Review article20252 citations
    ABI

  17. Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy

    Gyas Khan, Ali Hanbashi, Wedad Mawkili +7

    Article20252 citations
    ABI

  18. The Investigation of Nfκb Inhibitors to Block Cell Proliferation in OSCC Cells Lines

    Yuxi Cheng, Liping Wang, Shuju Zhang +4

    Article20242 citations
    ABI

  19. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

    Changsong Qi, Chang Liu, Jifang Gong +21

    Article20242 citations
    ABI

  20. Limits of CD133 as a marker of glioma self‐renewing cells

    Virginie Clément, Valérie Dutoit, Denis Marino +2

    Article20092 citations
    ABI

  21. Role of TRPM2 in brain tumours and potential as a drug target

    Delphine Ji, Zhengwei Luo, Andrea Ovcjak +4

    Review article20212 citations
    ABI

  22. Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43

    Franca Maria Tuccillo, Annamaria de Laurentiis, Camillo Palmieri +8

    Review article20142 citations
    ABI

  23. Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers

    Sylvain Julien, Aleksandar Ívetic, Anita Grigoriadis +11

    Article20112 citations
    ABI

  24. Biology and clinical relevance of EpCAM

    Laura Keller, Stefan Werner, Klaus Pantel

    Review article20192 citations
    ABI

  25. The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer

    Jung‐Tung Hung, I‐Ju Chen, Shir‐Hwa Ueng +8

    Article20222 citations
    ABI